|
ZBED3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8086200859766E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.91284790626878E-12 |
| Normal-vs-Stage2 |
1.54350000003411E-06 |
| Normal-vs-Stage3 |
1.85540471875356E-12 |
| Normal-vs-Stage4 |
1.90736315630602E-13 |
| Stage1-vs-Stage2 |
1.914290E-02 |
| Stage1-vs-Stage3 |
1.781440E-01 |
| Stage1-vs-Stage4 |
1.332210E-01 |
| Stage2-vs-Stage3 |
7.015600E-03 |
| Stage2-vs-Stage4 |
4.021700E-03 |
| Stage3-vs-Stage4 |
6.392400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.08655315248052E-12 |
| Normal-vs-AfricanAmerican |
1.155710E-04 |
| Normal-vs-Asian |
5.6850002483344E-10 |
| Caucasian-vs-AfricanAmerican |
2.098400E-02 |
| Caucasian-vs-Asian |
3.406600E-01 |
| AfricanAmerican-vs-Asian |
1.869430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65485419706602E-13 |
| Normal-vs-Female |
5.19484455452357E-12 |
| Male-vs-Female |
1.324410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70197189675036E-12 |
| Normal-vs-Age(41-60Yrs) |
9.28257470889093E-12 |
| Normal-vs-Age(61-80Yrs) |
3.84947629328281E-12 |
| Normal-vs-Age(81-100Yrs) |
1.081490E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.464200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.761600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.570800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.286200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.938200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.662200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.84610000000907E-06 |
| Classical-VS-Follicular |
6.069900E-02 |
| Classical-VS-Other |
3.089000E-01 |
| Classical-VS-Normal |
1.14009912621782E-11 |
| Tall-VS-Follicular |
1.09719999996649E-06 |
| Tall-VS-Other |
5.300400E-01 |
| Tall-VS-Normal |
8.88178419700125E-16 |
| Follicular-VS-Other |
1.533570E-01 |
| Follicular-VS-Normal |
7.34929994639089E-09 |
| Other-VS-Normal |
2.63540000000617E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.5230041934019E-11 |
| Normal-vs-N1 |
3.03412850399809E-12 |
| N0-vs-N1 |
1.166170E-01 |
|
|
